Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | BASF SE | 117 |
| 2 | Bayer CropScience AG | 10 |
| 3 | Bayer Intellectual Property GmbH | 6 |
| 4 | Compagnie Generale des Etablissements Michelin SCA | 5 |
| 5 | BASF Agro BV | 4 |
| 6 | Syngenta Participations AG | 4 |
| 7 | Lubrizol Advanced Materials Inc | 3 |
| 8 | Michelin Recherche et Technique SA Switzerland | 3 |
| 9 | Rohm and Haas Co | 3 |
| 10 | Bayer CropScience LP | 2 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A01N | Preservation of bodies; biocides; pest repellents | 190 |
| 2 | C07D | Heterocyclic compounds | 73 |
| 3 | A61P | Therapeutic activity (drug indications) | 18 |
| 4 | A61K | Medicinal preparations | 13 |
| 5 | Y02A | Climate change adaptation | 13 |
| 6 | C08G | Polymers from non-vinyl bonds (e.g. polyamides, polyesters) | 11 |
| 7 | C07F | Organometallic compounds | 10 |
| 8 | C08K | Polymer compositions (additives) | 10 |
| 9 | C07C | Acyclic and carbocyclic compounds | 7 |
| 10 | A61Q | Cosmetics, personal care | 6 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Fungal Plant Pathogen Control | 1 |
| 2 | Glutathione Transferases and Polymorphisms | 1 |
| 3 | Heavy Metal Exposure and Toxicity | 1 |
| 4 | Pesticide Exposure and Toxicity | 1 |
| 5 | Pesticide Residue Analysis and Safety | 1 |
| 6 | Trace Elements in Health | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Ashok Kumar Malik | Punjabi University | 9 |
| 2 | G. J. M. van der Kerk | Zorginstituut Nederland | 7 |
| 3 | A. Kaars Sijpesteijn | 5 | |
| 4 | Walker Em | John L. McClellan Memorial Veterans Hospital | 5 |
| 5 | Elizabeth Delzell | University of Alabama at Birmingham | 4 |
| 6 | W Młynarczyk | 4 | |
| 7 | David W. Pyatt | University of Colorado Health | 3 |
| 8 | J. Kaslander | 3 | |
| 9 | Maurizio Macaluso | University of Alabama at Birmingham | 3 |
| 10 | Nalini Sathiakumar | University of Alabama at Birmingham | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| A Novel Anticancer Gold(III) Dithiocarbamate Compound Inhibits the Activity of a Purified 20S Proteasome and 26S Proteasome in Human Breast Cancer Cell Cultures and Xenografts | 2006 | 319 | Metal complexes synthesis and properties |
| Enzymological Characterization of EpoA, a Laccase-Like Phenol Oxidase Produced by Streptomyces griseus | 2003 | 169 | Enzyme-mediated dye degradation |
| Adsorption performances and mechanisms of the newly synthesized N,N′-di (carboxymethyl) dithiocarbamate chelating resin toward divalent heavy metal ions from aqueous media | 2009 | 144 | Chemical Synthesis and Characterization |
| Analysis of Silver Nanoparticles in Antimicrobial Products Using Surface-Enhanced Raman Spectroscopy (SERS) | 2015 | 121 | Nanoparticles: synthesis and applications |
| Ziram Causes Dopaminergic Cell Damage by Inhibiting E1 Ligase of the Proteasome | 2008 | 88 | Autophagy in Disease and Therapy |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula of Dimethyldithiocarbamate?
Which organization holds the most patents involving Dimethyldithiocarbamate?
What are the primary patent classification areas for Dimethyldithiocarbamate?
What research topics are associated with Dimethyldithiocarbamate?
How many patents and papers on Dimethyldithiocarbamate have been published in the last three years?